XM does not provide services to residents of the United States of America.
A
A

Akamai

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

Akamai Extends Microsegmentation To Amazon Web Services

BRIEF-Akamai Extends Microsegmentation To Amazon Web Services Nov 19 (Reuters) - Akamai Technologies Inc AKAM.O : AKAMAI EXTENDS MICROSEGMENTATION TO AMAZON WEB SERVICES; ENHANCES ZTNA FOR OPTIMAL APPLICATION PERFORMANCE AKAMAI TECHNOLOGIES INC: ADDED NEW FEATURES TO ITS ZERO TRUST NETWORK ACCESS PRODUCT, AKAMAI ENTERPRISE APPLICATION ACCESS Source
A

Akamai Announces Winning Bid For Select Assets Of Edgio

BRIEF-Akamai Announces Winning Bid For Select Assets Of Edgio Nov 15 (Reuters) - Akamai Technologies Inc AKAM.O : AKAMAI ANNOUNCES WINNING BID FOR SELECT ASSETS OF EDGIO AKAMAI TECHNOLOGIES: NO ASSETS RELATED TO EDGIO NETWORK WOULD BE ACQUIRED AS PART OF BID Source text: ID:nPnbhnjS5a Further company coverage: AKAM.O
A

U.S. AMN Healthcare Services, Chart Industries, Home Depot

U.S. RESEARCH ROUNDUP-AMN Healthcare Services, Chart Industries, Home Depot Nov 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AMN Healthcare Services, Chart Industries and Home Depot on Wednesday. HIGHLIGHTS * AMN Healthcare Services Inc AMN.N : Jefferies cuts target price to $27 from $41 * Bristol-Myers Squibb Co BMY.N : JP Morgan raises target price to $70 from $64 * Chart Industries Inc GTLS.N : HSBC raises t
A
C
M
C

U.S. Akamai Technologies, Bill Holdings, Veeva Systems

U.S. RESEARCH ROUNDUP- Akamai Technologies, Bill Holdings, Veeva Systems Nov 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Akamai Technologies, Bill Holdings and Veeva Systems, on Monday. HIGHLIGHTS * Akamai Technologies Inc AKAM.O : HSBC raises target price to $121 from $107 * Bill Holdings Inc BILL.N : Jefferies raises target price to $92 from $65 * Charles River Laboratories International CRL.N : TD Cowen rai
A
E
E
A

S&P 500 top and bottom performing stocks at about 12:00 p.m. EST

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EST S&P 500 .SPX Top Performers Percent Change Axon Enterprise Inc AXON.OQ +20.2% Insulet Corp PODD.OQ +11.8% Fortinet Inc FTNT.OQ +7.5% Tesla Inc TSLA.OQ +7.1% Motorola Solutions Inc MSI.N +6.8% Bottom Performers Percent Change Akamai Technologies Inc AKAM.OQ -12.8% Airbnb Inc ABN
A
F
T
U
E
A
M

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.